Why are Americans so Suspicious of Social Medicine?

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2gzoD47 on November 30, 2016 at 03:23PM This UK economist spent a year in the U.S. to learn more about America’s health care system. Why does cost-per-Quality-Adjusted-Life-Year (QALY) generate so much fear? How credible are U.S. value frameworks without taking into account cost-per-QALY? Why does the U.S. have […]

from Market Design at http://bit.ly/2gx4XxB on November 30, 2016 at 05:38AM Frank McCormick points out this encouraging story from New Zealan, about removing financial disincentives from donating a kidney: ‘Recognising the heroes’ – MP’s bill will give organ donors full compo while they recover "Mr Bishop has steered a Member’s Bill into law that will […]

Science in the Age of Trump

from THCB at http://bit.ly/2gIjMxR on November 30, 2016 at 04:47AM By DAVID SHAYWITZ, MD As Donald Trump seeks to build his administration, he will likely struggle with creating a science infrastructure, given his estrangement from the nation’s scientific community. The distance between Trump and scientists seems to reflect mutual disdain. Trump famously trusts his gut […]

100 citations

from Healthcare Economist at http://bit.ly/2gF1mAz on November 30, 2016 at 12:42AM 100 citations Written By: Jason Shafrin – Nov• 30•16 This week I passed the 100 citation mark on Google Scholar.  This means over 100 peer-reviewed articles have cited my own peer-reviewed research. To take a look at my full list of publications, please visit my […]

Cochrane Collaboration Issue 11, 2016…

from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2gUgD18 on November 29, 2016 at 11:30PM ….is complete.  The website lists protocols and methodology papers as well, but we’ll just flag up the notable reviews; these being…… Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis Adjuvant platinum‐based chemotherapy for early stage cervical cancer Gene […]

National Psoriasis Foundation Talks ICER and Value Assessment

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2g2pF7X on November 29, 2016 at 09:46AM Dan Leonard, National Pharmaceutical Council President, recently talked with the Vice President of Government Relations and Advocacy, Leah Howard. Subjects discussed include value assessment frameworks and engagement with framework developers like the Institute for Clinical and Economic Review (ICER). Find out […]

Seema Verma to Head Centers for Medicare and Medicaid Services

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2gSfDKM on November 29, 2016 at 08:46AM Seema Verma, founder and CEO of a health policy firm, was recently selected to serve as Administrator of the Centers for Medicare and Medicaid Services. Verma has worked closely with Vice President-elect Mike Pence designing his Obamacare Medicaid expansion model. Learn […]

Healthcare Triage: Reference Pricing, CALPERS, and Reduced Health Care Costs

from The Incidental Economist at http://bit.ly/2gtaG7G on November 29, 2016 at 08:24AM Healthcare Triage: Reference Pricing, CALPERS, and Reduced Health Care Costs At a time when health care spending seems only to go up, an initiative in California has slashed the prices of many common procedures. The California Public Employees’ Retirement System (Calpers) started paying hospitals differently […]

Game theoretic questions and the Trump transition, on Bloomberg Surveillance

from Market Design at http://bit.ly/2g1v536 on November 29, 2016 at 05:57AM Early yesterday morning I was interviewed on Bloomberg Surveillance, about what I thought were some game theoretic questions facing the Trump transition and administration. We talked about cabinet choices as commitments, and trade and climate agreements as collective action problems… My contribution starts at minute […]